Amneal Pharmaceuticals, Inc. (AMRX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1247369,
    "name": "Amneal Pharmaceuticals, Inc.",
    "stock_name": "Amneal Pharmaceuticals, Inc.",
    "full_name": "Amneal Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/amneal-pharmaceuticals-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "11.94",
    "chg": -0.26,
    "chgp": "-2.09%",
    "dir": -1,
    "prev_price": "12.20",
    "mcapval": "2,906.34",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03168L1052",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "109.91 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amneal-pharmaceuticals-inc-1247369-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amneal-pharmaceuticals-inc-technically-bullish-or-bearish-3547813",
        "imagepath": "",
        "date": "2025-09-20 20:03:41",
        "description": "As of 5 September 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the monthly MACD and KST are mildly bearish, and the Dow Theory indicates a mildly bearish stance on the weekly timeframe. The OBV shows a mildly bullish trend on both weekly and monthly periods. \n\nIn terms of performance, Amneal has outperformed the S&P 500 over the past month (18.33% vs. 2.33%) and year-to-date (21.46% vs. 12.22%), but lags behind over the past year (13.85% vs. 17.14%) and longer periods. Overall, the current technical stance is bullish, with moderate strength driven by positive weekly indicators...."
      },
      {
        "title": "Is Amneal Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amneal-pharmaceuticals-inc-overvalued-or-undervalued-3544069",
        "imagepath": "",
        "date": "2025-09-20 18:36:46",
        "description": "As of 1 March 2024, the valuation grade for Amneal Pharmaceuticals, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, particularly highlighted by its P/E ratio of 58, which significantly exceeds the industry average, and a negative price-to-book value of -17.93. Additionally, the EV to EBITDA ratio stands at 7.91, which, while lower than some peers, still suggests a premium valuation relative to its earnings potential.\n\nIn comparison to peers, Amneal's P/E ratio of 48.88 is notably higher than that of NewAmsterdam Pharma Co. NV, which has a P/E of -20.32, and Ardelyx, Inc. with a P/E of -28.16, both indicating a challenging valuation landscape within the sector. Furthermore, despite recent stock performance showing a 21.46% year-to-date return compared to the S&P 500's 12.22%, the long-term returns of 337.27% o..."
      }
    ],
    "total": 7,
    "sid": "1247369",
    "stock_news_url": "https://www.marketsmojo.com/news/amneal-pharmaceuticals-inc-1247369"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Amneal Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 20:03:41

As of 5 September 2025, the technical trend for Amneal Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the monthly MACD and KST are mildly bearish, and the Dow Theory indicates a mildly bearish stance on the weekly timeframe. The OBV shows a mildly bullish trend on both weekly and monthly periods. In terms of performance, Amneal has outperformed the S&P 500 over the past month (18.33% vs. 2.33%) and year-to-date (21.46% vs. 12.22%), but lags behind over the past year (13.85% vs. 17.14%) and longer periods. Overall, the current technical stance is bullish, with moderate strength driven by positive weekly indicators....

Is Amneal Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:36:46

As of 1 March 2024, the valuation grade for Amneal Pharmaceuticals, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. The company appears to be overvalued, particularly highlighted by its P/E ratio of 58, which significantly exceeds the industry average, and a negative price-to-book value of -17.93. Additionally, the EV to EBITDA ratio stands at 7.91, which, while lower than some peers, still suggests a premium valuation relative to its earnings potential. In comparison to peers, Amneal's P/E ratio of 48.88 is notably higher than that of NewAmsterdam Pharma Co. NV, which has a P/E of -20.32, and Ardelyx, Inc. with a P/E of -28.16, both indicating a challenging valuation landscape within the sector. Furthermore, despite recent stock performance showing a 21.46% year-to-date return compared to the S&P 500's 12.22%, the long-term returns of 337.27% o...

View All News